BBVA USA Collaborates With Univfy For Express Healthcare Loan Program

Univfy, an AI platform company that has a mission is to improve fertility patients’ experience and access to in vitro fertilization (IVF), announced on Monday it has formed a collaboration with BBVA USA, the US subsidiary of global financial institution BBVA, to offer a finance program with rates starting at 0% APR (up to 18.99%). According to the duo, BBVA Express Healthcare Loan Program for IVF, which is expected to enable more individuals and couples to receive IVF treatment when needed, is available to patients at participating Univfy-affiliated IVF Centers.

“The new finance program offers fixed-interest rates, flexible loan terms, no application fees, and direct fund disbursement to the participating IVF center as quickly as 24 hours after the loan is closed.”

While sharing more details about the program, BBVA USA Executive Director of Business Execution, Shayan Khwaja, stated:

“At BBVA, our purpose is to bring the age of opportunity to everyone and I can think of no finer – or more rewarding – way to achieve that goal than by working with Univfy® to help those dedicated to making their dreams of a family come true. It’s our privilege to work with a company like Univfy that uses 21st century technologies to positively impact society and people. I can’t wait to measure our success in this program by the families we have helped.”

Dr. Mylene Yao, CEO and Co-Founder of Univfy, went on to add:

“I am thrilled and privileged that Univfy is bringing BBVA USA, a top 25 US bank with consumer lending expertise, to provide fertility patients with a better option to fund their IVF treatment. Navigating fertility treatment can be stressful both emotionally and financially. Our goal for this collaboration with BBVA is to help more women and couples build their families and as importantly, provide a funding option that may help reduce financial stress as they welcome their newborns.”



Sponsored Links by DQ Promote

 

 

Disclosure Quest

Reg A - Form 1-A Filings Beta

Beta. Initial Form 1-A only. Target raise is the stated Amount to be Raised, totaled. Compared with the same dates one year earlier.

YTD: Jan 1, 2026 - Oct 22, 2026 vs Jan 1, 2025 - Oct 22, 2025

Share this graph
Number of Filings131Prior 125 +4.8%
Target Raise, Total$3.40BPrior $3.54B -3.9%
This YTDYear priorChange
Filings 131 125 +4.8%
Target raise $3.40B $3.54B -3.9%

Sponsored by the Crowded Media Group the leading digital news service covering the global Fintech Industry, including digital assets, crowdfunding, tokenization, and other innovations in capital markets. email us @CrowdfundInside

Source: DisclosureQuest. Initial Form 1-A only.

Created by Crowded Media Group

This display counts initial Form 1-A filings only. It does not represent subsequent filings, including Form 1-A/A amendments or Form 1-A POS post-qualification updates filed by the issuer. Amounts are the stated Amount to be Raised on the initial filing, not capital raised and not amounts revised in later filings.

0 0 votes
Article Rating
Subscribe
Notify of
guest

This site uses Akismet to reduce spam. Learn how your comment data is processed.

0 Comments
Newest
Oldest Most Voted
 
0
Would love your thoughts, please comment.x
()
x
Send this to a friend